The higher frequency of Her2-positive lesions in DCIS compared with invasive breast cancer has been argued to occur due to loss of expression; however, it might indicate that in the breast cancer progression model, there may be lesions that do not frequently evolve into invasive breast cancers, including Her2-positive DCIS lesions. The gene discussed is ERBB2; the disease is breast cancer.